PortViewPortView
Avita Medical logo

Avita Medical (RCEL) Stock Analysis

NASDAQHealthcareMedical - Devices

$10.26+1.89%
1-year price historyRange $3.27 – $10.59
52-week range$10.26
$3.22$10.78

What Avita Medical does

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

Key metrics

Market cap
$254.89M
P/E (TTM)
-7.12
EPS (TTM)
$-1.44
Beta
1.85
Dividend yield
0.00%
Revenue / share
$2.46
50-day avg
$6.26
200-day avg
$4.65
52-week high
$10.78
52-week low
$3.22
CEO
Cary G. Vance

ETFs linked to RCEL

Broad-market and Healthcare sector ETFs an investor holding Avita Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how RCEL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze RCEL in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Avita Medical?
Avita Medical trades under the ticker RCEL on NASDAQ.
Which exchange is RCEL listed on?
RCEL is listed on NASDAQ.
What sector does Avita Medical operate in?
Avita Medical is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze RCEL in a portfolio?
PortView shows RCEL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.